2011 Scrip 100: Dragons, tigers and kangaroos
This article was originally published in Scrip
Executive Summary
Diverse, developed and developing, the Asian pharmaceutical markets have an appetite for both innovative products and branded generics. Bayer Schering Pharma's strategy for growth in the region includes investment in both, Alok Kanti tells Ian Haydock.